Company Overview of Biotica Technology Limited
Biotica Technology Limited engages in the discovery and development of drugs for the treatment of cancer and inflammatory diseases. It applies its technology to discover novel therapeutics based on polyketide leads, including mTOR inhibitors, Hsp90 inhibitors, apoptosis inducers, and angiogenesis inhibitors. The company was founded in 1996 and is headquartered in Little Chesterford, the United Kingdom.
Suite 5, Granta Park
Cambridge, CB21 6AD
Founded in 1996
Key Executives for Biotica Technology Limited
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Biotica Technology Limited, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.